SecBot SecBot
DEFA14A ·Filed Jun 5, 2026

CRBU

Caribou Biosciences, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001619856-26-000039
Proxy solicitation materials
Actionable Insight • Neutral

Routine proxy reminder, no trading signal. Monitor for any dissident activity or vote results post-June 17 meeting. The officer exculpation amendment is standard governance but could see opposition from governance-focused investors.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$1.84
T+0 close · Jun 5, 2026 · via day close
Latest settled
−0.54%
T+20 · $1.83
Vs SPY
−2.17%
α at T+20
Next horizon
T+60
due 3mo ago
  1. T+0 · Jun 8 $1.84entry
  2. T+1 · 5mo ago 0.00%α +0.29% · $1.84
  3. T+5 · 5mo ago −9.78%α −11.89% · $1.66
  4. T+20 · 4mo ago −0.54%α −2.17% · $1.83
  5. T+60 · due 3mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Caribou Biosciences filed a DEFA14A urging stockholders to vote ahead of the June 17, 2026 annual meeting. The board recommends voting FOR director elections, auditor ratification, an officer exculpation charter amendment, and an adjournment proposal. This is a routine solicitation reminder with no new financial or strategic information.

Key Financial Metrics

Vote
director election
Meeting
2026-06-17

Key Facts

  • Annual meeting scheduled for June 17, 2026
  • Board recommends voting FOR all four proposals: Class II director election, Deloitte ratification, officer exculpation amendment, and adjournment proposal
  • Filing is a reminder to vote, no new material information disclosed
  • D.F. King & Co. assisting with proxy solicitation

Financial Impact

No financial figures disclosed in this filing

Risk Factors

  • Low shareholder turnout could delay or fail the officer exculpation proposal
  • No dissident or activist context in this filing, risk of unexpected opposition is minimal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001619856-26-000039
Document: 0001619856-26-000039-index-headers.html0001619856-26-000039
Document: 0001619856-26-000039-index.html0001619856-26-000039
Document: 0001619856-26-000039.txt0001619856-26-000039

Track record

13 reports on CRBU

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +28.02% at T+20 after the Oct 6, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 7/10 Entry $0.4487 Now $0.3530 +21.33% settles Dec 7
  2. Oct 6, 20265w ago 8-K Bearish 7/10 Entry $0.6174 to $0.4444 Now $0.3530 +42.82% ▲ +28.02% +26.68% vs SPY
  3. Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $1.34 to $0.5190 Now $0.3530 −73.66% ▼ −61.27% −60.71% vs SPY
  4. Jun 11, 202622w ago 8-K Bullish 6/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
  5. Jun 11, 202622w ago Press Release Bullish 7/10 Entry $1.66 to $1.94 Now $0.3530 −78.73% ▲ +16.87% +14.98% vs SPY
  6. Jun 5, 202623w ago DEFA14A Neutral 2/10 Viewing Entry $1.84 to $1.83 Now $0.3530 −80.82% ▼ −0.54% −2.17% vs SPY
  7. Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $2.13 to $2.16 Now $0.3530 −83.43% ▲ +1.41% −3.55% vs SPY
  8. Mar 5, 202636w ago 8-K Mixed 5/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
  9. Mar 5, 202636w ago Press Release Mixed 6/10 Entry $1.82 to $1.95 Now $0.3530 −80.60% ▲ +7.14% +9.19% vs SPY
  10. Feb 28, 202637w ago Institutional Cluster Neutral 5/10 Entry $1.84 to $1.72 Now $0.3530 −80.82% ▼ −6.52% +1.42% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 5, 2026